chr2-202542302-A-G
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PS4_ModeratePVS1PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The BMPR2 c.1277-9A>G variant is a non-canonical splice site (-9) variant located in intron 9. The variant is absent from gnomAD v.2.1.1 and v4.1.0 (PM2_supporting) and was reported in four cases (PMID:18356561, 20534176, 27613157) (PS4_moderate). In silico prediction (SpliceAI) indicates likely loss of the acceptor splice site (score = 0.97). cDNA analysis demonstrates an aberrant splice product leading to premature truncation (p.Gly426Aspfs*47) and, thus, likely nonsense mediated decay (PMID:18356561 and private communication: Soubrier) (PVS1 (RNA)). No familial segregation data were available. In summary, the variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PVS1 (RNA), PM2_supporting, PS4_moderate (VCEP specification version v1.1, 1/18/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA645293838/MONDO:0015924/125
Frequency
Consequence
NM_001204.7 intron
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension    Pathogenic:1 
The BMPR2 c.1277-9A>G variant is a non-canonical splice site (-9) variant located in intron 9. The variant is absent from gnomAD v.2.1.1 and v4.1.0 (PM2_supporting) and was reported in four cases (PMID: 18356561, 20534176, 27613157) (PS4_moderate). In silico prediction (SpliceAI) indicates likely loss of the acceptor splice site (score = 0.97). cDNA analysis demonstrates an aberrant splice product leading to premature truncation (p.Gly426Aspfs*47) and, thus, likely nonsense mediated decay (PMID: 18356561 and private communication: Soubrier) (PVS1 (RNA)). No familial segregation data were available. In summary, the variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PVS1 (RNA), PM2_supporting, PS4_moderate (VCEP specification version v1.1, 1/18/2024). -
Pulmonary venoocclusive disease 1;C4552070:Pulmonary hypertension, primary, 1    Pathogenic:1 
PM2_Supporting+PVS1+PS4 -
Pulmonary hypertension, primary, 1    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at